PubMed

Therapeutische Arzneimittel für autologe Chondrozyten und Vergleich der regulatorischen Systeme in Zielstaaten.

PMID: 35582708 · 2022-05-03

J, i, w, o, n, , K, i, m, ;, , J, a, e, h, o, n, g, , P, a, r, k, ;, , S, e, u, n, g, -, Y, e, o, n, , S, o, n, g, ;, , E, u, n, y, o, u, n, g, , K, i, m

ZeitschriftRegenerative therapy

Jahr2022-05-03

PMID35582708

Zusammenfassung

Autologous chondrocytes (ACs) are Human cell/tissue-based products used for the treatment of joint cartilage defects. Regulatory agencies have established regulations related to ACs to ensure their safety and efficacy. This study investigated the status and characteristics of ACs approved worldwide. Furthermore, the AC-related regulations were compared by country to provide reference materials for the development of product approval procedures. This study reviewed the current status of global AC

Offizielle Quelle

Auf PubMed ansehen →

Daten aus PubMed / NCBI. Den Volltext und die aktuellsten Informationen finden Sie stets im offiziellen Eintrag.